MIR371A and breast cancer: Higher expression of members of the C19MC and MIR371-3 clusters has also been reported in thyroid adenomas [50] and parathyroid carcinomas [48], germ cell tumors [29,51,52], retinoblastoma [53], breast cancer [54], gastric adenocarcinoma [55] and esophageal cancer [56,57], among others.